drugset / Trial / NCT00392925
A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety, tolerability, and effect on body weight of leptin, injected subcutaneously, in combination with pramlintide, injected subcutaneously.
Timeline
- Start
- 2006-10
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metreleptin | Protein / enzyme biologic | 5 mg | Subcutaneous |
| Subject | Pramlintide | Peptide | 360 ug | Subcutaneous |